Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00148668
Status:
COMPLETED
Last Update Posted:
2013-04-09
First Post:
2005-09-07
Brief Title:
Preoperative HerceptinNavelbine Versus TaxotereCarboplatinHerceptin in HER-2 Positive Breast Cancer
Sponsor:
Eric Winer MD
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
03-311
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eric Winer MD
Lead Sponsor Class:
OTHER
Responsible Party:
Eric Winer MD
Responsible Party Title:
Chief Division of Womens Cancers
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Dana-Farber Cancer Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Yale University | OTHER |
| Dana-Farber Cancer Institute | OTHER |
| Brigham and Womens Hospital | OTHER |
| Massachusetts General Hospital | OTHER |
| Beth Israel Deaconess Medical Center | OTHER |